Literature DB >> 8136102

Colocalization of 11 beta-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells.

L Kornel1.   

Abstract

Colocalization of mineralocorticoid receptors (MR) and 11 beta-hydroxysteroid dehydrogenase (11-HSD), the enzyme acting as a protector of MR, in the same cell of mineralocorticoid (MC)-responsive tissues is crucial to the concept of enzymic regulation of intracellular cortisol levels in these tissues. Such colocalization was demonstrated in the epithelial cells of the renal distal tubule. The aim of the present study was to examine if MR and 11-HSD activity can be colocalized in cells of another target tissue to mineralocorticoids, the arteries. Vascular smooth muscle (VSM) cells were cultured, and absence of dedifferentiation was ascertained up to the eighth passage. High affinity binding of [3H]aldosterone (ALDO) was demonstrated in the intact cultured cells, and Kd and Bmax values were calculated from Scatchard plots. The activity of 11-HSD was demonstrated in the cultured cells by incubating them with [3H]-cortisol in the presence of cofactors, and isolating [3H]-cortisone. Other [3H]-metabolites formed were 11 beta-hydroxy- and 11-keto-androstenedione. These data support the view that arterial tree is a target organ for mineralocorticoids and may be of importance in the pathogenetic mechanism of MC-induced hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8136102     DOI: 10.1093/ajh/7.1.100

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

Review 1.  Aldosterone as a determinant of cardiovascular and renal dysfunction.

Authors:  M Epstein
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

Review 2.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

Review 3.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

4.  Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.

Authors:  P Ye; T Yamashita; D M Pollock; H Sasano; W E Rainey
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

5.  The prevalence of primary aldosteronism in diabetic patients.

Authors:  Dijana Jefic; Naushaba Mohiuddin; Rana Alsabbagh; Margaret Fadanelli; Susan Steigerwalt
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-04       Impact factor: 3.738

Review 6.  The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.

Authors:  Murray Epstein; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

7.  Alterations in the long non‑coding RNA transcriptome in mesangial cells treated with aldosterone in vitro.

Authors:  Gaoting Qu; Huimin Shi; Bin Wang; Shanwen Li; Aiqing Zhang; Weihua Gan
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

8.  Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis.

Authors:  Qing Zeng; XiaoDuo Zhou; Ge Xu
Journal:  Drug Des Devel Ther       Date:  2019-05-03       Impact factor: 4.162

9.  Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke.

Authors:  Quynh N Dinh; Thiruma V Arumugam; Morag J Young; Grant R Drummond; Christopher G Sobey; Sophocles Chrissobolis
Journal:  Exp Transl Stroke Med       Date:  2012-10-30

10.  Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7).

Authors:  William C Valinsky; Anna Jolly; Perrine Miquel; Rhian M Touyz; Alvin Shrier
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.